{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:37:18Z","timestamp":1794947838482,"version":"4.9.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We explored the associations of comorbidities with cognitive deterioration, institutionalization, and mortality in biomarker-confirmed Alzheimer\u2019s disease (AD) dementia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a Swedish Register-based cohort study consisting of 10,857 people (mean age 74 years) with diagnosed dementia and positive AD biomarkers (CSF A\u03b2\n                      <jats:sub>42<\/jats:sub>\n                      \/P-tau\n                      <jats:sub>181<\/jats:sub>\n                      ratio). Cognitive function was measured by mini-mental state examination (MMSE). Comorbidities by human body organ systems (e.g., diseases of the circulatory system) and six selected comorbidities: type-2 diabetes (T2DM), ischemic heart disease (IHD), stroke, chronic kidney disease (CKD), inflammatory bowel disease, and depression, were analyzed. Multistate Cox regressions assessed the associations of comorbidities with cognitive deterioration, institutionalization, and death.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Only T2DM and IHD were associated with cognitive deterioration. Mental disorders, T2DM, and stroke were linked to higher hazards of institutionalization. Endocrine-metabolic disorders, circulatory system diseases, and CKD were associated with higher mortality rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Comorbidities may help inform the prognosis of biomarker-confirmed AD dementia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-025-01807-6","type":"journal-article","created":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T02:47:27Z","timestamp":1752288447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comorbidities predict institutionalization and mortality in biomarker-confirmed alzheimer\u2019s disease"],"prefix":"10.1186","volume":"17","author":[{"given":"Xin","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels Juul","family":"Brogaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Mourer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Areovimata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Eriksdotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Skillb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linus","family":"J\u00f6nsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,12]]},"reference":[{"key":"1807_CR1","doi-asserted-by":"crossref","unstructured":"2024 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2024;20(5):3708\u2013\u2009821.","DOI":"10.1002\/alz.13809"},{"issue":"10258","key":"1807_CR2","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"Global burden","year":"2020","unstructured":"Global burden. Of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204\u201322.","journal-title":"Lancet"},{"issue":"5","key":"1807_CR3","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.14283\/jpad.2024.153","volume":"11","author":"F Jessen","year":"2024","unstructured":"Jessen F, Kramberger MG, Angioni D, Aarsland D, Balasa M, Bennys K, et al. Progress in the treatment of alzheimer\u2019s disease is Needed - Position statement of European alzheimer\u2019s disease consortium (EADC) investigators. J Prev Alzheimers Dis. 2024;11(5):1212\u20138.","journal-title":"J Prev Alzheimers Dis"},{"issue":"3","key":"1807_CR4","doi-asserted-by":"publisher","first-page":"362","DOI":"10.14283\/jpad.2023.30","volume":"10","author":"J Cummings","year":"2023","unstructured":"Cummings J, Apostolova L, Rabinovici GD, Atri A, Aisen P, Greenberg S, et al. Lecanemab: appropriate use recommendations. J Prev Alzheimers Dis. 2023;10(3):362\u201377.","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"1807_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early alzheimer\u2019s disease. N Engl J Med. 2023;388(1):9\u201321.","journal-title":"N Engl J Med"},{"issue":"6","key":"1807_CR6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, et al. Donanemab in early symptomatic alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023;330(6):512\u201327.","journal-title":"JAMA"},{"key":"1807_CR7","doi-asserted-by":"publisher","first-page":"101860","DOI":"10.1016\/j.eclinm.2023.101860","volume":"57","author":"SR Chowdhury","year":"2023","unstructured":"Chowdhury SR, Chandra Das D, Sunna TC, Beyene J, Hossain A. Global and regional prevalence of Multimorbidity in the adult population in community settings: a systematic review and meta-analysis. EClinicalMedicine. 2023;57:101860.","journal-title":"EClinicalMedicine"},{"issue":"9","key":"1807_CR8","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1136\/jnnp-2024-333468","volume":"95","author":"R Dobson","year":"2024","unstructured":"Dobson R, Patterson K, Malik R, Mandal U, Asif H, Humphreys R, et al. Eligibility for antiamyloid treatment: Preparing for disease-modifying therapies for alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 2024;95(9):796\u2013803.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"1807_CR9","doi-asserted-by":"publisher","first-page":"e12360","DOI":"10.1002\/trc2.12360","volume":"8","author":"F Landeiro","year":"2022","unstructured":"Landeiro F, Morton J, Gustavsson A, Potashman M, Lecomte P, Belger M, et al. Health economic modeling for alzheimer\u2019s disease: expert perspectives. Alzheimers Dement (N Y). 2022;8(1):e12360.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"1","key":"1807_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3233\/JAD-201364","volume":"80","author":"EE Smith","year":"2021","unstructured":"Smith EE, Ismail Z. Mortality risk models for persons with dementia: A systematic review. J Alzheimers Dis. 2021;80(1):103\u201311.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"1807_CR11","doi-asserted-by":"publisher","first-page":"e0177044","DOI":"10.1371\/journal.pone.0177044","volume":"12","author":"ML Haaksma","year":"2017","unstructured":"Haaksma ML, Vilela LR, Marengoni A, Calderon-Larranaga A, Leoutsakos JS, Olde Rikkert MGM, et al. Comorbidity and progression of late onset alzheimer\u2019s disease: A systematic review. PLoS ONE. 2017;12(5):e0177044.","journal-title":"PLoS ONE"},{"issue":"2","key":"1807_CR12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3233\/JAD-180476","volume":"66","author":"YN Song","year":"2018","unstructured":"Song YN, Wang P, Xu W, Li JQ, Cao XP, Yu JT, et al. Risk factors of rapid cognitive decline in alzheimer\u2019s disease and mild cognitive impairment: A systematic review and Meta-Analysis. J Alzheimers Dis. 2018;66(2):497\u2013515.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"1807_CR13","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.clinthera.2015.01.002","volume":"37","author":"H Ascher-Svanum","year":"2015","unstructured":"Ascher-Svanum H, Chen YF, Hake A, Kahle-Wrobleski K, Schuster D, Kendall D, et al. Cognitive and functional decline in patients with mild alzheimer dementia with or without comorbid diabetes. Clin Ther. 2015;37(6):1195\u2013205.","journal-title":"Clin Ther"},{"issue":"1","key":"1807_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000514651","volume":"50","author":"SL Kao","year":"2021","unstructured":"Kao SL, Wang JH, Chen SC, Li YY, Yang YL, Lo RY. Impact of comorbidity burden on cognitive decline: A prospective cohort study of older adults with dementia. Dement Geriatr Cogn Disord. 2021;50(1):43\u201350.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"2","key":"1807_CR15","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3233\/JAD-170665","volume":"61","author":"C Ferrari","year":"2018","unstructured":"Ferrari C, Lombardi G, Polito C, Lucidi G, Bagnoli S, Piaceri I, et al. Alzheimer\u2019s disease progression: factors influencing cognitive decline. J Alzheimers Dis. 2018;61(2):785\u201391.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1807_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12877-021-02130-z","volume":"21","author":"B Rajamaki","year":"2021","unstructured":"Rajamaki B, Hartikainen S, Tolppanen AM. The effect of comorbidities on survival in persons with alzheimer\u2019s disease: a matched cohort study. BMC Geriatr. 2021;21(1):173.","journal-title":"BMC Geriatr"},{"issue":"1","key":"1807_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/alz.12635","volume":"19","author":"SC Chung","year":"2023","unstructured":"Chung SC, Providencia R, Sofat R, Pujades-Rodriguez M, Torralbo A, Fatemifar G, et al. Incidence, morbidity, mortality and disparities in dementia: A population linked electronic health records study of 4.3 million individuals. Alzheimers Dement. 2023;19(1):123\u201335.","journal-title":"Alzheimers Dement"},{"key":"1807_CR18","doi-asserted-by":"crossref","unstructured":"De Matteis G, Burzo ML, Della Polla DA, Serra A, Russo A, Landi F et al. Outcomes and predictors of In-Hospital mortality among older patients with dementia. J Clin Med. 2022;12(1).","DOI":"10.3390\/jcm12010059"},{"issue":"1","key":"1807_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13195-018-0348-0","volume":"10","author":"HFM Rhodius-Meester","year":"2018","unstructured":"Rhodius-Meester HFM, Liedes H, Koene T, Lemstra AW, Teunissen CE, Barkhof F, et al. Disease-related determinants are associated with mortality in dementia due to alzheimer\u2019s disease. Alzheimers Res Ther. 2018;10(1):23.","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"1807_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jamda.2018.06.020","volume":"20","author":"ML Haaksma","year":"2019","unstructured":"Haaksma ML, Rizzuto D, Ramakers I, Garcia-Ptacek S, Marengoni A, van der Flier WM, et al. The impact of frailty and comorbidity on institutionalization and mortality in persons with dementia: A prospective cohort study. J Am Med Dir Assoc. 2019;20(2):165\u201370. e2.","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"1807_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3233\/JAD-221259","volume":"94","author":"N Buawangpong","year":"2023","unstructured":"Buawangpong N, Pinyopornpanish K, Phinyo P, Jiraporncharoen W, Angkurawaranon C, Soontornpun A. Effect of comorbidities on Ten-Year survival in patients with dementia. J Alzheimers Dis. 2023;94(1):163\u201375.","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"1807_CR22","doi-asserted-by":"publisher","first-page":"861","DOI":"10.30773\/pi.2023.0112","volume":"20","author":"C-S Chu","year":"2023","unstructured":"Chu C-S, Cheng S-L, Bai Y-M, Su T-P, Tsai S-J, Chen T-J, et al. Multimorbidity pattern and risk for mortality among patients with dementia: A nationwide cohort study using latent class analysis. Psychiatry Investig. 2023;20(9):861\u20139.","journal-title":"Psychiatry Investig"},{"issue":"5","key":"1807_CR23","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1212\/WNL.0000000000008745","volume":"94","author":"ML Haaksma","year":"2020","unstructured":"Haaksma ML, Eriksdotter M, Rizzuto D, Leoutsakos JS, Olde Rikkert MGM, Melis RJF, et al. Survival time tool to guide care planning in people with dementia. Neurology. 2020;94(5):e538\u201348.","journal-title":"Neurology"},{"issue":"1","key":"1807_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s40273-022-01212-z","volume":"41","author":"L Jonsson","year":"2023","unstructured":"Jonsson L, Tate A, Frisell O, Wimo A. The costs of dementia in europe: an updated review and Meta-analysis. PharmacoEconomics. 2023;41(1):59\u201375.","journal-title":"PharmacoEconomics"},{"issue":"1","key":"1807_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13195-022-01053-0","volume":"14","author":"A Mank","year":"2022","unstructured":"Mank A, van Maurik IS, Rijnhart JJM, Bakker ED, Bouteloup V, Le Scouarnec L, et al. Development of multivariable prediction models for institutionalization and mortality in the full spectrum of alzheimer\u2019s disease. Alzheimers Res Ther. 2022;14(1):110.","journal-title":"Alzheimers Res Ther"},{"issue":"12","key":"1807_CR26","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/gps.2058","volume":"23","author":"M Harboun","year":"2008","unstructured":"Harboun M, Dorenlot P, Cohen N, Steinhagen-Thiessen E, Ankri J. Impact of hip fracture, heart failure and weight loss on the risk of institutionalization of community-dwelling patients with dementia. Int J Geriatr Psychiatry. 2008;23(12):1245\u201352.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"2","key":"1807_CR27","doi-asserted-by":"publisher","first-page":"e0116538","DOI":"10.1371\/journal.pone.0116538","volume":"10","author":"D Religa","year":"2015","unstructured":"Religa D, Fereshtehnejad SM, Cermakova P, Edlund AK, Garcia-Ptacek S, Granqvist N, et al. SveDem, the Swedish dementia Registry - a tool for improving the quality of diagnostics, treatment and care of dementia patients in clinical practice. PLoS ONE. 2015;10(2):e0116538.","journal-title":"PLoS ONE"},{"key":"1807_CR28","unstructured":"Socialstyrelsen. Nationella riktlinjer: demenssjukdom. 2017."},{"issue":"1\u20132","key":"1807_CR29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000366194","volume":"39","author":"F Falahati","year":"2015","unstructured":"Falahati F, Fereshtehnejad SM, Religa D, Wahlund LO, Westman E, Eriksdotter M. The use of MRI, CT and lumbar puncture in dementia diagnostics: data from the SveDem registry. Dement Geriatr Cogn Disord. 2015;39(1\u20132):81\u201391.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"5","key":"1807_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/alzrt212","volume":"5","author":"T Skillb\u00e4ck","year":"2013","unstructured":"Skillb\u00e4ck T, Zetterberg H, Blennow K, Mattsson N. Cerebrospinal fluid biomarkers for alzheimer disease and subcortical axonal damage in 5,542 clinical samples. Alzheimers Res Ther. 2013;5(5):47.","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"1807_CR31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1515\/cclm-2021-0651","volume":"60","author":"J Gobom","year":"2022","unstructured":"Gobom J, Parnetti L, Rosa-Neto P, Vyhnalek M, Gauthier S, Cataldi S, et al. Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid. Clin Chem Lab Med. 2022;60(2):207\u201319.","journal-title":"Clin Chem Lab Med"},{"issue":"11","key":"1807_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v098.i11","volume":"98","author":"C Thiele","year":"2021","unstructured":"Thiele C, Hirschfeld G. Cutpointr: improved Estimation and validation of optimal cutpoints in R. J Stat Softw. 2021;98(11):1\u201327.","journal-title":"J Stat Softw"},{"key":"1807_CR33","unstructured":"Socialstyrelsen. Statistical register\u2019s production and quality National Patient Register. 2022."},{"key":"1807_CR34","doi-asserted-by":"publisher","first-page":"101045","DOI":"10.1016\/j.arr.2020.101045","volume":"64","author":"G Grande","year":"2020","unstructured":"Grande G, Qiu C, Fratiglioni L. Prevention of dementia in an ageing world: evidence and biological rationale. Ageing Res Rev. 2020;64:101045.","journal-title":"Ageing Res Rev"},{"key":"1807_CR35","doi-asserted-by":"publisher","first-page":"830064","DOI":"10.3389\/fneur.2022.830064","volume":"13","author":"DM Kelly","year":"2022","unstructured":"Kelly DM, Rothwell PM. Disentangling the relationship between chronic kidney disease and cognitive disorders. Front Neurol. 2022;13:830064.","journal-title":"Front Neurol"},{"key":"1807_CR36","doi-asserted-by":"publisher","first-page":"110610","DOI":"10.1016\/j.pnpbp.2022.110610","volume":"119","author":"D Wang","year":"2022","unstructured":"Wang D, Zhang X, Du H. Inflammatory bowel disease: A potential pathogenic factor of alzheimer\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry. 2022;119:110610.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1807_CR37","doi-asserted-by":"publisher","first-page":"821866","DOI":"10.3389\/fnagi.2022.821866","volume":"14","author":"A Hakim","year":"2022","unstructured":"Hakim A. Perspectives on the complex links between depression and dementia. Front Aging Neurosci. 2022;14:821866.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"1807_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s44192-023-00057-y","volume":"4","author":"DW Fisher","year":"2024","unstructured":"Fisher DW, Dunn JT, Dong H. Distinguishing features of depression in dementia from primary psychiatric disease. Discov Ment Health. 2024;4(1):3.","journal-title":"Discov Ment Health"},{"key":"1807_CR39","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish National inpatient register. BMC Public Health. 2011;11:450.","journal-title":"BMC Public Health"},{"issue":"2","key":"1807_CR40","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/00365521.2016.1246605","volume":"52","author":"GL Jakobsson","year":"2017","unstructured":"Jakobsson GL, Sterneg\u00e5rd E, Ol\u00e9n O, Myrelid P, Ljung R, Strid H, et al. Validating inflammatory bowel disease (IBD) in the Swedish National patient register and the Swedish quality register for IBD (SWIBREG). Scand J Gastroenterol. 2017;52(2):216\u201321.","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"1807_CR41","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1177\/14034948211061016","volume":"50","author":"AC Meyer","year":"2022","unstructured":"Meyer AC, Sandstrom G, Modig K. Nationwide data on home care and care home residence: presentation of the Swedish social service register, its content and coverage. Scand J Public Health. 2022;50(7):946\u201358.","journal-title":"Scand J Public Health"},{"issue":"9","key":"1807_CR42","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","volume":"32","author":"HL Brooke","year":"2017","unstructured":"Brooke HL, Talb\u00e4ck M, H\u00f6rnblad J, Johansson LA, Ludvigsson JF, Druid H, et al. The Swedish cause of death register. Eur J Epidemiol. 2017;32(9):765\u201373.","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"1807_CR43","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1001\/archneurol.2009.55","volume":"66","author":"BJ Snider","year":"2009","unstructured":"Snider BJ, Fagan AM, Roe C, Shah AR, Grant EA, Xiong C, et al. Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the alzheimer type. Arch Neurol. 2009;66(5):638\u201345.","journal-title":"Arch Neurol"},{"issue":"2","key":"1807_CR44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1474-4422(18)30371-5","volume":"18","author":"LMK Wallace","year":"2019","unstructured":"Wallace LMK, Theou O, Godin J, Andrew MK, Bennett DA, Rockwood K. Investigation of frailty as a moderator of the relationship between neuropathology and dementia in alzheimer\u2019s disease: a cross-sectional analysis of data from the rush memory and aging project. Lancet Neurol. 2019;18(2):177\u201384.","journal-title":"Lancet Neurol"},{"key":"1807_CR45","unstructured":"Therneau T. A Package for Survival Analysis in R 2024 [Available from: https:\/\/CRAN.R-project.org\/package=survival"},{"issue":"7","key":"1807_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v038.i07","volume":"38","author":"LC de Wreede","year":"2011","unstructured":"de Wreede LC, Fiocco M, Putter H. Mstate: an R package for the analysis of competing risks and Multi-State models. J Stat Softw. 2011;38(7):1\u201330.","journal-title":"J Stat Softw"},{"issue":"1","key":"1807_CR47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","volume":"1","author":"KJ Rothman","year":"1990","unstructured":"Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1(1):43\u20136.","journal-title":"Epidemiology"},{"issue":"7139","key":"1807_CR48","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1136\/bmj.316.7139.1236","volume":"316","author":"TV Perneger","year":"1998","unstructured":"Perneger TV. What\u2019s wrong with bonferroni adjustments. BMJ. 1998;316(7139):1236\u20138.","journal-title":"BMJ"},{"issue":"10","key":"1807_CR49","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","volume":"14","author":"GJ Biessels","year":"2018","unstructured":"Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14(10):591\u2013604.","journal-title":"Nat Rev Endocrinol"},{"issue":"10452","key":"1807_CR50","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston G, Huntley J, Liu KY, Costafreda SG, Selb\u00e6k G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the lancet standing commission. Lancet. 2024;404(10452):572\u2013628.","journal-title":"Lancet"},{"issue":"1","key":"1807_CR51","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s13195-021-00934-0","volume":"13","author":"J Secnik","year":"2021","unstructured":"Secnik J, Xu H, Schwertner E, Hammar N, Alvarsson M, Winblad B, et al. The association of antidiabetic medications and Mini-Mental state examination scores in patients with diabetes and dementia. Alzheimers Res Ther. 2021;13(1):197.","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"1807_CR52","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3233\/JAD-180896","volume":"68","author":"A Kaczynski","year":"2019","unstructured":"Kaczynski A, Michalowsky B, Eichler T, Thyrian JR, Wucherer D, Zwingmann I, et al. Comorbidity in dementia diseases and associated health care resources utilization and cost. J Alzheimers Dis. 2019;68(2):635\u201346.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"1807_CR53","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1017\/S1041610216001654","volume":"29","author":"S Toot","year":"2017","unstructured":"Toot S, Swinson T, Devine M, Challis D, Orrell M. Causes of nursing home placement for older people with dementia: a systematic review and meta-analysis. Int Psychogeriatr. 2017;29(2):195\u2013208.","journal-title":"Int Psychogeriatr"},{"issue":"12","key":"1807_CR54","doi-asserted-by":"publisher","first-page":"e84014","DOI":"10.1371\/journal.pone.0084014","volume":"8","author":"RJ Melis","year":"2013","unstructured":"Melis RJ, Marengoni A, Rizzuto D, Teerenstra S, Kivipelto M, Angleman SB, et al. The influence of Multimorbidity on clinical progression of dementia in a population-based cohort. PLoS ONE. 2013;8(12):e84014.","journal-title":"PLoS ONE"},{"issue":"1","key":"1807_CR55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/ageing\/afp202","volume":"39","author":"M Luppa","year":"2010","unstructured":"Luppa M, Luck T, Weyerer S, Konig HH, Brahler E, Riedel-Heller SG. Prediction of institutionalization in the elderly. A systematic review. Age Ageing. 2010;39(1):31\u20138.","journal-title":"Age Ageing"},{"issue":"6","key":"1807_CR56","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1136\/injuryprev-2016-042192","volume":"23","author":"K Brown","year":"2017","unstructured":"Brown K, Cameron ID, Keay L, Coxon K, Ivers R. Functioning and health-related quality of life following injury in older people: a systematic review. Inj Prev. 2017;23(6):403\u201311.","journal-title":"Inj Prev"},{"key":"1807_CR57","doi-asserted-by":"publisher","first-page":"263355652211284","DOI":"10.1177\/26335565221128432","volume":"12","author":"R Dunn","year":"2022","unstructured":"Dunn R, Clayton E, Wolverson E, Hilton A. Conceptualising comorbidity and Multimorbidity in dementia: A scoping review and syndemic framework. J Multimorb Comorb. 2022;12:26335565221128432.","journal-title":"J Multimorb Comorb"},{"issue":"1","key":"1807_CR58","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1159\/000355079","volume":"3","author":"K Eska","year":"2013","unstructured":"Eska K, Graessel E, Donath C, Schwarzkopf L, Lauterberg J, Holle R. Predictors of institutionalization of dementia patients in mild and moderate stages: a 4-year prospective analysis. Dement Geriatr Cogn Dis Extra. 2013;3(1):426\u201345.","journal-title":"Dement Geriatr Cogn Dis Extra"}],"updated-by":[{"DOI":"10.1186\/s13195-026-02072-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000}}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01807-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01807-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01807-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:02:24Z","timestamp":1779256944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-025-01807-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,12]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1807"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01807-6","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,12]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article was revised: some numbers under column \u201cNo. events\/No. people at risk\u201d in Table 3 are shown as months.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13195-026-02072-x","URL":"https:\/\/doi.org\/10.1186\/s13195-026-02072-x","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received approval from the Swedish Ethical Review Authority (DNR: 2023-06581-02). Written consent was not necessary for this study, as the study is a national register-based study. However, patients have been informed about the registration and have the right to decline to be registered in SveDem.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Maria Eriksdotter has served as a consultant for Roche, Biogen, Bioarctic, Lilly and Novo Nordisk A\/S and has given lectures in symposia sponsored by Roche. Henrik Zetterberg has served at scientific advisory boards and\/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Alzecure, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator. Silke Kern has served on scientific advisory boards, speaker and\/or consultant for Roche, Geras Solutions, Optoceutics, Eli Lilly, Biogen, Novo Nordisk A\/S, Merry Life, Triolab and Bioarctic. Linus J\u00f6nsson has received consulting fees from H. Lundbeck A\/S, Novo Nordisk A\/S and TEVA Inc, and license fees for the Resource Utilization in Dementia (RUD) instrument. Others report no conflicts of interest pertinent to this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"155"}}